Browse drugs

…cant clinical challenge. Although research has often focused on aspirin,1 the risks associated with P2Y12 inhibitors or dual antiplatel…

…omography), and histological/MPM strut coverage were evaluated. Rosuvastatin serum concentration was correlated with endothelial cell covera…

…ment complex. After control of her PNH, she was then changed to aspirin only, as protection for her PNH-associated moyamoya-like vascul…

…in minor but disabling strokes.Dual antiplatelet treatment with aspirin and clopidogrel was more effective than aspirin alone for reduc…

…icipate in anti-platelet research with a majority in support of clopidogrel genotyping within a trial. Acknowledging patient preferences fo…

…sions in leads I, aVL, V5, V6). He was treated accordingly with aspirin, clopidogrel and morphine, and percutaneous coronary interventi…

…in the UK due to insufficient evidence.The protective effect of aspirin in reducing colorectal cancer risk among individuals with Lynch…

…ntiplatelet therapy preoperatively (96.7%), 12 patients were on aspirin monotherapy (3%), and 1 patient was on no antiplatelet agent. A…

…rction. The patient was initiated on dual antiplatelet therapy (aspirin 325 mg daily and clopidogrel 75 mg daily) for secondary stroke …

…p of 4.3 months [IQR 0.4-6.8].Treatment strategies consisted of aspirin in 52.7% patients, anticoagulation alone in 9.1% patients, and …

…ee patients, our experience aligns with adult data and supports cangrelor’s feasibility as an adjunct or bridge in acute pediatric neuroi…

… patient’s intermittent compliance and subtherapeutic dosing of rivaroxaban. Anticoagulation was optimized by increasing rivaroxaban to ful…